Skip to main content
AI Market Summary
Loading market intelligence...

EyePoint, Inc. (EYPT) Stock Forecast 2025 - AI Price Prediction & Analysis


EyePoint, Inc. (EYPT) AI Stock Price Forecast & Investment Analysis

EyePoint, Inc. Stock Price Chart and Technical Analysis

Loading EyePoint, Inc. interactive price chart and technical analysis...

EyePoint, Inc. (EYPT) - Comprehensive Stock Analysis & Investment Research

Deep dive into EyePoint, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about EyePoint, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For EyePoint, Inc.: EyePoint, Inc. operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

EyePoint, Inc. (Stock Symbol: EYPT) is a leading company in the Industrial Applications and Services sector , specifically operating within the Laboratory Analytical Instruments industry.

The organization employs approximately 157 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing EyePoint, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For EyePoint, Inc.: With $42M in annual revenue and -146.3% net margin, the company demonstrates developing profitability.

Annual Revenue: $42 million generating a -146.3% net profit margin .

Market Capitalization: $1120 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -47.5% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for EyePoint, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For EyePoint, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for EyePoint, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: EyePoint, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For EyePoint, Inc.: Market positioning analysis based on available financial and operational metrics.

EyePoint, Inc. strategically competes in the highly dynamic Laboratory Analytical Instruments marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy -226.6% gross margin, indicating strong pricing power and operational efficiency.

EyePoint, Inc. (EYPT) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for EyePoint, Inc. stock analysis.

Loading EyePoint, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into EyePoint, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if EyePoint, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For EyePoint, Inc.: With a P/E ratio of -4.43, the market sees the stock as potentially undervalued.

P/E Ratio -4.43x
P/B Ratio 5.59x
Market Cap $1120M
EPS $-2.69
Book Value/Share $2.88
Revenue/Share $0.61
FCF/Share $-2.68
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently EyePoint, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For EyePoint, Inc.: An ROE of -47.5% indicates room for improvement in shareholder value creation.

ROE -47.5%
ROA -31.1%
ROIC -33.2%
Gross Margin -226.6%
Operating Margin -152.6%
Net Margin -146.3%
EBT Margin -172.5%
Tax Rate 1.5%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess EyePoint, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For EyePoint, Inc.: A current ratio of 6.87 indicates strong liquidity.

Current Ratio 6.87x
Quick Ratio 6.58x
D/E Ratio 0.18x
Financial Leverage 1.46x
Interest Coverage -11.6x
Working Capital $48M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal EyePoint, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For EyePoint, Inc.: Free cash flow of $-55M indicates cash challenges that need attention.

Operating Cash Flow $-55M
Free Cash Flow $-55M
FCF/Sales -142.5%
CapEx/Sales 0.4%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively EyePoint, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For EyePoint, Inc.: An asset turnover of 0.18x suggests room for improvement in asset utilization.

Asset Turnover 0.18x
Receivables Turnover 2.4x
Inventory Turnover 1.9x
Fixed Assets Turnover 13.7x
Days Sales Outstanding 150 days
Days Inventory 190 days
Payables Period 280 days
Cash Conversion Cycle 59 days
Understanding Financial Statement Data

What these metrics mean: Key figures from EyePoint, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For EyePoint, Inc.: With annual revenue of $42M, EyePoint, Inc. represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $42M
Operating Income $-10M
Net Income $-9M
R&D Expense $9M
SG&A Expense $148M
Cost of Goods Sold $-30M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 90%
Cash & Short-term Investments 78%
Total Liabilities 32%
Short-term Debt 4%
Accounts Receivable 8%
Inventory 1%
Dividend & Shareholder Information
Shares Outstanding 70M
Growth Metrics (YoY)
EPS Growth -30.6%

Latest EyePoint, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting EyePoint, Inc. (EYPT) stock price and investment outlook.

, source: Yahoo Finance

WATERTOWN, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of ...

, source: Yahoo Finance

– LUCIA pivotal Phase 3 trial enrolled and randomized over 400 patients in seven months, demonstrating continued strong enthusiasm for the DURAVYU pivotal program across the global retinal community – ...

EyePoint, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of EyePoint, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
A Unlock Forecast - 30 Days FREE Trial $40517M 33.2x 6.4x
ASTC Unlock Forecast - 30 Days FREE Trial $6M 28.9x 0.3x
AVTR Unlock Forecast - 30 Days FREE Trial $7821M 15.5x 1.4x
BFNH Unlock Forecast - 30 Days FREE Trial $16M x x
BIO Unlock Forecast - 30 Days FREE Trial $8593M 29.6x 1.3x
BIO-B Unlock Forecast - 30 Days FREE Trial $8504M 24.6x 1.3x
BNGO Unlock Forecast - 30 Days FREE Trial $6M 0.0x 0.1x
BRKR Unlock Forecast - 30 Days FREE Trial $7020M 74.6x 2.9x
CTKB Unlock Forecast - 30 Days FREE Trial $641M 82.0x 1.7x
EYPT Unlock Forecast - 30 Days FREE Trial $1120M -4.4x 5.6x
HBIO Unlock Forecast - 30 Days FREE Trial $34M -8.3x 2.4x
ILMN Unlock Forecast - 30 Days FREE Trial $21421M 30.5x 9.0x
LAB Unlock Forecast - 30 Days FREE Trial $566M -2.4x 1.4x
LCTC Unlock Forecast - 30 Days FREE Trial $7M x 1.3x
MTD Unlock Forecast - 30 Days FREE Trial $30825M 31.5x -136.9x
NAUT Unlock Forecast - 30 Days FREE Trial $250M -3.8x 1.5x
PACB Unlock Forecast - 30 Days FREE Trial $643M -1.5x 17.8x
PRPO Unlock Forecast - 30 Days FREE Trial $42M -1.2x 2.9x
QTRX Unlock Forecast - 30 Days FREE Trial $359M -11.1x 1.1x
RPID Unlock Forecast - 30 Days FREE Trial $177M -0.9x 4.0x
RVTY Unlock Forecast - 30 Days FREE Trial $11850M 49.9x 1.6x
SCND Unlock Forecast - 30 Days FREE Trial $8M x 0.6x
SEER Unlock Forecast - 30 Days FREE Trial $119M -2.0x 0.4x
TXG Unlock Forecast - 30 Days FREE Trial $2050M -8.6x 2.6x
WAT Unlock Forecast - 30 Days FREE Trial $23346M 36.0x 10.0x

Frequently Asked Questions - EyePoint, Inc. Stock Forecast

How accurate are EyePoint, Inc. stock predictions?

Our AI model shows a 23% Spearman correlation coefficient for EYPT predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence EyePoint, Inc. stock price forecasts?

Our analysis considers EyePoint, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is EyePoint, Inc. a good investment in 2025?

Based on our AI analysis, EyePoint, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are EyePoint, Inc. forecasts updated?

EyePoint, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced EyePoint, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for EyePoint, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...